Implementing in Practice

First introduced globally in 2008, Selenia Dimensions breast tomosynthesis holds many exciting clinical possibilities to help find and fight breast cancer earlier than ever before. The majority of clinical studies show the future potential of using Hologic’s breast tomosynthesis is in screening; all patients, regardless of dense or fatty breasts, are found to benefit from tomosynthesis^1-2. However, implementation paths may vary depending on the number of tomosynthesis systems available at the site.

Please contact your Hologic territory manager to discuss options.